Literature DB >> 19794354

Comorbidity in psychiatry: its impact on psychopharmacological treatment.

Slobodan Loga1, Svjetlana Loga-Zec.   

Abstract

The existence of two or more diagnoses (psychiatric, or a combination with somatic) in one person leads to a dilemma when choosing psychopharmacs for the treatment of the patient. There are no acceptable and comprehensive guidelines or algorithms for the treatment of innumerable possible combinations of psychiatric and somatic disorders. A strategy for treatment of such conditions is needed.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19794354

Source DB:  PubMed          Journal:  Psychiatr Danub        ISSN： 0353-5053            Impact factor:   1.063


  4 in total

1.  [Comparison of three methods for measuring multiple morbidity according to the use of health resources in primary healthcare].

Authors:  Antoni Sicras-Mainar; Soledad Velasco-Velasco; Ruth Navarro-Artieda; Milagrosa Blanca Tamayo; Alba Aguado Jodar; Amador Ruíz Torrejón; Alexandra Prados-Torres; Concepción Violan-Fors
Journal:  Aten Primaria       Date:  2011-10-19       Impact factor: 1.137

2.  DSM-5 cross-cutting symptom measures: a step towards the future of psychiatric care?

Authors:  Diana E Clarke; Emily A Kuhl
Journal:  World Psychiatry       Date:  2014-10       Impact factor: 49.548

3.  Evaluation of the construct reliability and validity of the DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure-Chinese version in maintenance hemodialysis patients.

Authors:  Shao-Jun Ma; Wen-Ji Wang; Min Tang; Han Chen; Feng Ding
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

4.  Prevalence of comorbid anxiety disorders in schizophrenia.

Authors:  Chandra Kiran; Suprakash Chaudhury
Journal:  Ind Psychiatry J       Date:  2016 Jan-Jun
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.